1. Biogen earnings + surprise news about Alzheimer’s drug aducanumab — Bristol-Myers makes Opdivo pitch for frontline lung cancer — Criticism of ProPublica’s latest analysis of physician payment data — See more on our front page news

    TRY TWO WEEKS OF OUR EMAIL NEWS HEADLINES FOR FREE
    Dismiss Notice
  2. Think you have witnessed fraud?Ask a Whistleblower Attorney -- a chance to discuss whistleblower-related legal issues with practicing whistleblower attorneys.
    Dismiss Notice

Adolor STILL F*cking around with the FDA...LMAO

Discussion in 'Adolor' started by Anonymous, Sep 13, 2007 at 7:26 PM.

Tags: Add Tags
  1. Anonymous

    Anonymous Guest

    FDA Needs More Review Time for Adolor
    Thursday September 13, 8:40 am ET
    Adolor Says FDA Needs More Time to Review the Application for Entereg


    EXTON, Pa. (AP) -- Biotechnology company Adolor Corp. said Thursday the Food and Drug Administration will need more time to review the company's application for its experimental constipation treatment Entereg.
    The FDA requested additional information in June as part of a "approvable letter" in November. The drug is being developed with GlaxoSmithKline PLC. The companies halted studies on the drug in April after data showed patients taking the drug were more prone to benign and cancerous lesions, fractures and cardiovascular events.
     
  2. Anonymous

    Anonymous Guest

    lol
     
  3. Anonymous

    Anonymous Guest

    chea!